UC Davis Dermatology Online Journal
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Use of Biologic Agents in the Treatment of Oral Lesions Due to Pemphigus and Behçet's Disease: a Systematic Review
Davis GE, Sarandev G, Vaughan AT, Al-Eryani K, Enciso R. The Use of Biologic Agents in the Treatment of Oral Lesions due to Pemphigus and Behçet’s Disease: A Systematic Review. J Anesthesiol & Pain Therapy. 2020;1(1):14-23 Systematic Review Open Access The Use of Biologic Agents in the Treatment of Oral Lesions due to Pemphigus and Behçet’s Disease: A Systematic Review Gerald E. Davis II1,2, George Sarandev1, Alexander T. Vaughan1, Kamal Al-Eryani3, Reyes Enciso4* 1Advanced graduate, Master of Science Program in Orofacial Pain and Oral Medicine, Herman Ostrow School of Dentistry of USC, Los Angeles, California, USA 2Assistant Dean of Academic Affairs, Assistant Professor, Restorative Dentistry, Meharry Medical College, School of Dentistry, Nashville, Tennessee, USA 3Assistant Professor of Clinical Dentistry, Division of Periodontology, Dental Hygiene & Diagnostic Sciences, Herman Ostrow School of Dentistry of USC, Los Angeles, California, USA 4Associate Professor (Instructional), Division of Dental Public Health and Pediatric Dentistry, Herman Ostrow School of Dentistry of USC, Los Angeles, California, USA Article Info Abstract Article Notes Background: Current treatments for pemphigus and Behçet’s disease, such Received: : March 11, 2019 as corticosteroids, have long-term serious adverse effects. Accepted: : April 29, 2020 Objective: The objective of this systematic review was to evaluate the *Correspondence: efficacy of biologic agents (biopharmaceuticals manufactured via a biological *Dr. Reyes Enciso, Associate Professor (Instructional), Division source) on the treatment of intraoral lesions associated with pemphigus and of Dental Public Health and Pediatric Dentistry, Herman Ostrow Behçet’s disease compared to glucocorticoids or placebo. School of Dentistry of USC, Los Angeles, California, USA; Email: [email protected]. -
Genital Dermatology
GENITAL DERMATOLOGY BARRY D. GOLDMAN, M.D. 150 Broadway, Suite 1110 NEW YORK, NY 10038 E-MAIL [email protected] INTRODUCTION Genital dermatology encompasses a wide variety of lesions and skin rashes that affect the genital area. Some are found only on the genitals while other usually occur elsewhere and may take on an atypical appearance on the genitals. The genitals are covered by thin skin that is usually moist, hence the dry scaliness associated with skin rashes on other parts of the body may not be present. In addition, genital skin may be more sensitive to cleansers and medications than elsewhere, emphasizing the necessity of taking a good history. The physical examination often requires a thorough skin evaluation to determine the presence or lack of similar lesions on the body which may aid diagnosis. Discussion of genital dermatology can be divided according to morphology or location. This article divides disease entities according to etiology. The clinician must determine whether a genital eruption is related to a sexually transmitted disease, a dermatoses limited to the genitals, or part of a widespread eruption. SEXUALLY TRANSMITTED INFECTIONS AFFECTING THE GENITAL SKIN Genital warts (condyloma) have become widespread. The human papillomavirus (HPV) which causes genital warts can be found on the genitals in at least 10-15% of the population. One study of college students found a prevalence of 44% using polymerase chain reactions on cervical lavages at some point during their enrollment. Most of these infection spontaneously resolved. Only a minority of patients with HPV develop genital warts. Most genital warts are associated with low risk HPV types 6 and 11 which rarely cause cervical cancer. -
The Tamilnadu Dr. M.G.R. Medical University Chennai, Tamil Nadu
CLINICO-PATHOLOGICAL STUDY OF SKIN SURFACE EPIDERMAL AND APPENDAGEAL TUMOURS Dissertation Submitted in partial fulfillment of university regulations for M.D. DEGREE IN DERMATOLOGY, VENEREOLOGY AND LEPROSY BRANCH XII – A THE TAMILNADU DR. M.G.R. MEDICAL UNIVERSITY CHENNAI, TAMIL NADU SEPTEMBER 2006 CERTIFICATE This is to certify that this Dissertation entitled “CLINICO-PATHOLOGICAL STUDY OF SKIN SURFACE EPIDERMAL AND APPENDAGEAL TUMOURS” is a bonafide work done by DR.G.BALAJI, Postgraduate student of Department of Dermatology, Leprosy and Institute of STD, Madras Medical College and Government General Hospital, Chennai – 3 for the award of Degree of M.D.( Dermatology, Venereology and Leprosy ) Branch XII – A during the academic year of 2003-2006. This work has not previously formed in the basis for the award of any degree or diploma. Prof. Dr. B. Parveen, MD., DD., Professor & Head, Dept. of Dermatology and Leprosy, Madras Medical College & Govt. General Hospital, Chennai – 3. Prof. Dr. Kalavathy Ponniraivan, MD., The Dean Madras Medical College & Govt. General Hospital, Chennai – 3. SPECIAL ACKNOWLEDGEMENT I sincerely thank Prof. Dr. Kalavathy Ponniraivan, MD., Dean, Madras Medical College & Govt. General Hospital, Chennai – 3, for granting me permission to use the resources of this institution for my study. ACKNOWLEDGEMENT I sincerely thank Prof. B.Parveen MD.,DD, Professor and Head of Department of Dermatology for her invaluable guidance and encouragement for the successful completion of this study. I express my heart felt gratitude to Dr.N.Gomathy MD.,DD, former Head of department of Dermatology who was instrumental in the initiation of this project, giving constant guidance throughout my work. -
Fundamentals of Dermatology Describing Rashes and Lesions
Dermatology for the Non-Dermatologist May 30 – June 3, 2018 - 1 - Fundamentals of Dermatology Describing Rashes and Lesions History remains ESSENTIAL to establish diagnosis – duration, treatments, prior history of skin conditions, drug use, systemic illness, etc., etc. Historical characteristics of lesions and rashes are also key elements of the description. Painful vs. painless? Pruritic? Burning sensation? Key descriptive elements – 1- definition and morphology of the lesion, 2- location and the extent of the disease. DEFINITIONS: Atrophy: Thinning of the epidermis and/or dermis causing a shiny appearance or fine wrinkling and/or depression of the skin (common causes: steroids, sudden weight gain, “stretch marks”) Bulla: Circumscribed superficial collection of fluid below or within the epidermis > 5mm (if <5mm vesicle), may be formed by the coalescence of vesicles (blister) Burrow: A linear, “threadlike” elevation of the skin, typically a few millimeters long. (scabies) Comedo: A plugged sebaceous follicle, such as closed (whitehead) & open comedones (blackhead) in acne Crust: Dried residue of serum, blood or pus (scab) Cyst: A circumscribed, usually slightly compressible, round, walled lesion, below the epidermis, may be filled with fluid or semi-solid material (sebaceous cyst, cystic acne) Dermatitis: nonspecific term for inflammation of the skin (many possible causes); may be a specific condition, e.g. atopic dermatitis Eczema: a generic term for acute or chronic inflammatory conditions of the skin. Typically appears erythematous, -
Exacerbation of Galli-Galli Disease Following Dialysis Treatment: a Case Report and Review of Aggravating Factors
Open Access Case Report DOI: 10.7759/cureus.15401 Exacerbation of Galli-Galli Disease Following Dialysis Treatment: A Case Report and Review of Aggravating Factors Tejas P. Joshi 1 , Sally Shaver 2 , Jaime Tschen 3 1. Dermatology, Baylor College of Medicine, Houston, USA 2. Dermatology, Conroe Dermatology Associates, Conroe, USA 3. Dermatology, St. Joseph Dermatopathology, Houston, USA Corresponding author: Tejas P. Joshi, [email protected] Abstract Galli-Galli disease (GGD) is a rare genodermatosis that is an acantholytic variant of Dowling-Degos disease that presents as lentigo-like macules/papules with progressive reticulated hyperpigmentation. Heat, sweat, ultraviolet light exposure, and topical retinoids have been reported to exacerbate the lesions associated with GGD. Here, we present a 77-year-old woman with end-stage renal disease and GGD who reported a worsening of lesions during the summer months and following hemodialysis treatment. Despite the severity of her lesions following dialysis, she refused treatment with isotretinoin out of concern for its side effect profile. In this case report, we discuss some available treatment options for GGD and review the exacerbating factors for GGD currently reported in the literature. Categories: Dermatology Keywords: galli-galli disease, dowling-degos disease, genodermatosis, dialysis, contact dermatitis, end-stage renal disease Introduction Galli-Galli disease (GGD) is a rare, autosomal dominant genodermatosis that is an acantholytic variant of Dowling-Degos disease (DDD). DDD encompasses a spectrum of skin conditions that present with progressive reticulated hyperpigmentation; while GGD was initially postulated to be a distinct entity from DDD, more recent evidence has led to the consensus that GGD is a variant of DDD [1]. -
Histopathology of Porphyria Cutanea Tarda 133
HISTOPATHOLOGY OF PORPHYRIA CTJTANEA TARDA*t MATJRIMAURI FELDAKER, FELDAKER, M.D., MD., HAMILTON MONTGOMERY, M.D. AND LOUIS A. BRUNSTING, M.D.MD. We wish to report the results of the histopathologic examination of the skin in 11 patients \vithwith porphyria cutanea tardatarda whowho werewere examinedexamined betweenbetween 19461946 and 1954. The microscopic findings in two patients (numbers I nndand 2) havehnve beenbeen reported previously by Brunsting and Mason (1). A preliminary report of the histopathologic findings in the first 10 patients has been given by Brunsting (2). MATERIAL Eleven patients, 10 men and one woman, with porphyria cutanea tarda were included in this study. One or more cutaneous biopsy specimens from each patient were fixed with 10 per cent formalin and stained with hematoxylin and eosin,eosiu, various elastic-tissue stains such as elastin H (Grubler), and an modified aldehyde-fuchsin stain (3)t whichwhich wewe preferprefer toto thethe elastinelastin HH oror WeigertWeigert stain, stain van Gieson stain forfor collagen,collagen, periodicperiodic acid acid Schiff Schiff stain stain (P.A.S., (PAS., that is, Hotch- kiss-McManus stain) for polysaccharides with and without pretreatment with diastase, mucin stains such as mucin D (4) counterstained with 2 per cent indigo carmine, Mallory's potassium ferrocyanide stain for the demonstration of hemo- siderin, and silver nitrate stain counterstained with\vith hematoxylin to demonstrate melanin. Stains for amyloid, Maresch-Bielschowsky stain for reticulum fibers (Gitterfasern) arid the Giemsa stain to demonstrate mast cells were done on all specimens. Biopsy was performed on the dorsum of the hand or finger iiiin about 50 per cent of the patients and, with one exception, all specimens were removed from thethe usuallyusually exposed areas of the body. -
Cutaneous Horn: a Potentially Malignant Entity
Letter to the editor Cutaneous horn: a potentially malignant entity Cutaneous horn: a potentially malignant entity N. F. Fernandes, S. Sinha, W. C. Lambert, and R. A. Schwartz S UMMARY A cutaneous horn is a conical, dense, hyperkeratotic protrusion that often appears similar to the horn of an animal. It is a morphologic designation referring to an unusually cohesive keratinized material, not a true pathologic diagnosis. Cutaneous horns occur in association with, or as a re- sponse to, a wide variety of underlying benign, pre-malignant, and malignant cutaneous diseases. The most important common concern is distinguishing a hyperkeratotic actinic keratosis from a cutaneous squamous cell carcinoma. Keratoacanthoma is another cause, as illustrated herein as a projective cutaneous tumor with a fingernail-like appearance. The treatment of choice for cuta- neous horns is shave excision with subsequent histopathologic evaluation to rule out underlying malignancy and to guide potential further therapy. KEYIntroduction with the characterization of cutaneous horns as a WORDS medical disorder in the late eighteenth century (2). A cutaneous horn is a conical, dense hyperkeratotic cutaneous protrusion that often resembles the horn of an Epidemiology and etiology horn, cornu animal. The earliest documented case of cutaneous cutaneum, horn, or cornu cutaneum, was that of an elderly Welsh Cutaneous horns are nodules composed of hyperkerato- woman in London who was displayed commercially compact keratin that project above the surface of sis, actinic as an anomaly of nature in 1588 (1). There were the skin. They differ from animal horns by the keratosis, several other accounts of cutaneous horns in the absence of a central bone. -
Hair Loss in Infancy
SCIENCE CITATIONINDEXINDEXED MEDICUS INDEX BY (MEDLINE) EXPANDED (ISI) OFFICIAL JOURNAL OF THE SOCIETÀ ITALIANA DI DERMATOLOGIA MEDICA, CHIRURGICA, ESTETICA E DELLE MALATTIE SESSUALMENTE TRASMESSE (SIDeMaST) VOLUME 149 - No. 1 - FEBRUARY 2014 Anno: 2014 Lavoro: 4731-MD Mese: Febraury titolo breve: Hair loss in infancy Volume: 149 primo autore: MORENO-ROMERO No: 1 pagine: 55-78 Rivista: GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA Cod Rivista: G ITAL DERMATOL VENEREOL G ITAL DERMATOL VENEREOL 2014;149:55-78 Hair loss in infancy J. A. MORENO-ROMERO 1, R. GRIMALT 2 Hair diseases represent a signifcant portion of cases seen 1Department of Dermatology by pediatric dermatologists although hair has always been Hospital General de Catalunya, Barcelona, Spain a secondary aspect in pediatricians and dermatologists 2Universitat de Barcelona training, on the erroneous basis that there is not much in- Universitat Internacional de Catalunya, Barcelona, Spain formation extractable from it. Dermatologists are in the enviable situation of being able to study many disorders with simple diagnostic techniques. The hair is easily ac- cessible to examination but, paradoxically, this approach is often disregarded by non-dermatologist. This paper has Embryology and normal hair development been written on the purpose of trying to serve in the diag- nostic process of daily practice, and trying to help, for ex- ample, to distinguish between certain acquired and some The full complement of hair follicles is present genetically determined hair diseases. We will focus on all at birth and no new hair follicles develop thereafter. the data that can be obtained from our patients’ hair and Each follicle is capable of producing three different try to help on using the messages given by hair for each types of hair: lanugo, vellus and terminal. -
Pemphigoid Diseases: Pathogenesis, Diagnosis, and Treatment
Autoimmunity, February 2012; 45(1): 55–70 q Informa UK, Ltd. ISSN 0891-6934 print/1607-842X online DOI: 10.3109/08916934.2011.606447 Pemphigoid diseases: Pathogenesis, diagnosis, and treatment MICHAEL KASPERKIEWICZ1, DETLEF ZILLIKENS1, & ENNO SCHMIDT1,2 1Department of Dermatology, University of Lu¨beck, Lu¨beck, Germany, and 2Comprehensive Center for Inflammation Medicine, University of Lu¨beck, Lu¨beck, Germany (Submitted 25 June 2011; accepted 12 July 2011) Abstract Pemphigoid diseases (including bullous pemphigoid, mucous membrane pemphigoid, pemphigoid gestationis, linear IgA dermatosis, lichen planus pemphigoides, and anti-p200 pemphigoid) are a subgroup of autoimmune bullous skin diseases characterized by an autoantibody response toward structural components of the hemidesmosome resulting in subepidermal blistering. By the use of different in vitro systems and experimental animal models, the pathogenic relevance of these autoantibodies has been demonstrated. Recent advances in the understanding of autoantibody responses have led to novel diagnostic tools and a more differentiated therapeutic approach for these disorders. This review covers the most recent understanding of the pathophysiology, diagnosis, and treatment of this group of autoimmune diseases. Keywords: Pemphigoid, skin, antibody, antigen Introduction may be due to the increasing age of the general population and/or an increased awareness leading to The pemphigoid group of diseases is characterized by further diagnostic steps. MMP and PG have been For personal use only. subepidermal blisters due to autoantibody-induced disruption of the components of the dermal– identified as the second most frequent pemphigoid epidermal anchoring complex. Pemphigoid diseases diseases in central Europe with an incidence of two include bullous pemphigoid (BP), mucous membrane new patients/million/year [1]. -
Download Article
SKINTEST Skin Test Christina P. Linton 1. Which fungal strain is the most common cause 6. Which of the following conditions is characterized of tinea capitis in the United Kingdom and by intraepidermal blistering? North America? a. Bullous pemphigoid a. Trichophyton tonsurans b. Porphyria cutanea tarda b. Microsporum audouinii c. Herpesvirus infection c. Trichophyton rubrum d. Dermatitis herpetiformis d. Microsporum canis 7. What is the mechanism of action of injectable local 2. What percentage of cells in the epidermis are anesthetics? keratinocytes? a. Blockage of potassium channels a. 50% b. Inhibition of cyclooxygenase b. 65% c. Blockage of sodium channels c. 80% d. Inhibition of prostaglandins d. 95% 8. Which of the following statements most accurately 3. Which of the following conditions is inherited in describes pemphigus vulgaris? X-linked fashion? a. Onset is most common in the third and fourth a. Tuberous sclerosis decades of life. b. Incontinenta pigmenti b. Initial lesions generally occur on the trunk. c. Ataxia telangiectasia c. Auspitz sign is usually positive. d. Neurofibromatosis d. Untreated disease is commonly fatal. 4. What does the Greek root of the term ‘‘ichthyosis’’ 9. What does the term ‘‘acantholysis’’ refer to on a mean? dermatopathology report? a. Fish a. Loss of intercellular connections b. Crocodile b. Reduced thickness of the granular layer c. Elephant c. Abnormal retention of keratinocyte nuclei d. Lizard d. Intercellular edema 5. Lichen striatus most commonly occurs in which 10. Approximately what percentage of untreated anatomic location? syphilis cases progressed to tertiary syphilis? a. Face a. 15% b. Chest b. 33% c. Abdomen c. -
Expert-Level Diagnosis of Nonpigmented Skin Cancer by Combined Convolutional Neural Networks
Supplementary Online Content Tschandl P, Rosendahl C, Akay BN, et al. Expert-level diagnosis of nonpigmented skin cancer by combined convolutional neural networks. JAMA Dermatol. Published online November 28, 2018. doi:10.1001/jamadermatol.2018.4378 eFigure. Sensitivities (Blue) and Specificities (Orange) at Different Threshold Cutoffs (Green) of the Combined Classifier Evaluated on the Validation Set eAppendix. Neural Network Training eTable 1. Complete List of Diagnoses and Their Frequencies Within the Test-Set eTable 2. Education of Users According to Their Experience Group eTable 3. Percent of Correct Prediction of the Malignancy Status for Specific Diagnoses of a CNN Using Either Close-up or Dermatoscopic Images This supplementary material has been provided by the authors to give readers additional information about their work. © 2018 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/25/2021 eFigure. Sensitivities (Blue) and Specificities (Orange) at Different Threshold Cutoffs (Green) of the Combined Classifier Evaluated on the Validation Set A threshold cut at 0.2 (black) is found for a minimum of 51.3% specificity. © 2018 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/25/2021 eAppendix. Neural Network Training We compared multiple architecture and training hyperparameter combinations in a grid-search fashion, and used only the single best performing network for dermoscopic and close-up images, based on validation accuracy, for further analyses. We trained four different CNN architectures (InceptionResNetV2, InceptionV3, Xception, ResNet50) and used model definitions and ImageNet pretrained weights as available in the Tensorflow (version 1.3.0)/ Keras (version 2.0.8) frameworks. -
Review Skin Changes Are One of the Earliest Signs of Venous a R T I C L E Hypertension
pp 11 - 19 ABSTRACT Review Skin changes are one of the earliest signs of venous A R T I C L E hypertension. Some of these changes such as venous eczema are common and easily identified whereas DERMATOLOGICAL other changes such as acroangiodermatitis are less common and more difficult to diagnose. Other vein MANIFESTATIONS OF VENOUS related and vascular disorders can also present with specific skin signs. Correct identification of these DISEASE: PART I skin changes can aid in making the right diagnosis and an appropriate plan of management. Given KUROSH PARSI, MBBS, MSc(Med), FACD, FACP the significant overlap between phlebology and Departments of Dermatology, St. Vincent’s Hospital and dermatology, it is essential for phlebologists to be Sydney Children’s Hospital familiar with skin manifestations of venous disease. Sydney Skin & Vein Clinic, This paper is the first installment in a series of 3 Bondi Junction, NSW, Australia and discusses the dermatological manifestations of venous insufficiency as well as other forms of vascular ectasias that may present in a similar Introduction fashion to venous incompetence. atients with venous disease often exhibit dermatological Pchanges. Sometimes these skin changes are the only clue to an appropriate list of differential diagnoses. Venous ulceration. Less common manifestations include pigmented insufficiency is the most common venous disease which purpuric dermatoses, and acroangiodermatitis. Superficial presents with a range of skin changes. Most people are thrombophlebitis (STP) can also occur in association with familiar with venous eczema, lipodermatosclerosis and venous incompetence but will be discussed in the second venous ulcers as manifestations of long-term venous instalment of this paper (Figure 2).